Rezulin PowerPoint PPT Presentations

All Time
Show:
Recommended
Sort by:
PowerPoint Presentation Rezulin PowerPoint PPT Presentation
PowerPoint Presentation Rezulin - People with diabetes (millions) Amos AF, McCarty DJ, Zimmet P. ... Glucose Transport/Phosphorylation Is Decreased in Type 2 Diabetes and Prediabetic Offspring ...
People with diabetes (millions) Amos AF, McCarty DJ, Zimmet P. ... Glucose Transport/Phosphorylation Is Decreased in Type 2 Diabetes and Prediabetic Offspring ...
| PowerPoint PPT presentation | free to view
Recent Withdrawals PowerPoint PPT Presentation
Recent Withdrawals - Title: Developing Consumer Marketing Claims within the Clinical Development Process Author: Lou Morris Created Date: 9/29/2000 3:30:09 PM Document presentation format
Title: Developing Consumer Marketing Claims within the Clinical Development Process Author: Lou Morris Created Date: 9/29/2000 3:30:09 PM Document presentation format
| PowerPoint PPT presentation | free to download
TROGLITAZONE: PRESENTATION TO ADVISORY COMMITTEE PowerPoint PPT Presentation
TROGLITAZONE: PRESENTATION TO ADVISORY COMMITTEE - Marketing in US began March 97. Adv Cmt (12/11/96) 8-0 vote for AP ... Adv Cmt (3/26/99) 11-1 B R for concomitant use with insulin; 12-0 B R for ...
Marketing in US began March 97. Adv Cmt (12/11/96) 8-0 vote for AP ... Adv Cmt (3/26/99) 11-1 B R for concomitant use with insulin; 12-0 B R for ...
| PowerPoint PPT presentation | free to download
WITHDRAWN OR REMOVED DRUG PRODUCTS PowerPoint PPT Presentation
WITHDRAWN OR REMOVED DRUG PRODUCTS - Must not compound drugs that appear on a list published in the Federal ... Analgesic and antipyretic. Caused agranulocytosis. Declared a 'new drug' in 1964 ...
Must not compound drugs that appear on a list published in the Federal ... Analgesic and antipyretic. Caused agranulocytosis. Declared a 'new drug' in 1964 ...
| PowerPoint PPT presentation | free to download
Antidiabetic Drugs PowerPoint PPT Presentation
Antidiabetic Drugs - Lecture 14 Chapter 46 Antidiabetic Drugs Antidiabetic Drugs Drugs used to control diabetes mellitus - a chronic disease that affects carbohydrate metabolism 2 groups ...
Lecture 14 Chapter 46 Antidiabetic Drugs Antidiabetic Drugs Drugs used to control diabetes mellitus - a chronic disease that affects carbohydrate metabolism 2 groups ...
| PowerPoint PPT presentation | free to download
Pharmacology PowerPoint PPT Presentation
Pharmacology - Diminish side effects of estrogen therapy. Nausea, fluid retention, breast tenderness ... Antihypertensives & psychoactive drugs. sildenafil (Viagra ...
Diminish side effects of estrogen therapy. Nausea, fluid retention, breast tenderness ... Antihypertensives & psychoactive drugs. sildenafil (Viagra ...
| PowerPoint PPT presentation | free to view
Potential role of PPAR activation in CV risk reduction PowerPoint PPT Presentation
Potential role of PPAR activation in CV risk reduction - in CV risk reduction Genetic background Food intake excess Physical inactivity Obesity Hyperglycemia Hyperinsulinemia Insulin Dyslipidemia Inflammation
in CV risk reduction Genetic background Food intake excess Physical inactivity Obesity Hyperglycemia Hyperinsulinemia Insulin Dyslipidemia Inflammation
| PowerPoint PPT presentation | free to view
Diabetes and The Gastrointestinal Tract PowerPoint PPT Presentation
Diabetes and The Gastrointestinal Tract - Diabetes and The Gastrointestinal Tract Jeffrey I. Brown, M.D. Knoxville Gastrointestinal Specialists * * * * * * * * * * DIABETES - NONALCOHOLIC FATTY LIVER DISEASE ...
Diabetes and The Gastrointestinal Tract Jeffrey I. Brown, M.D. Knoxville Gastrointestinal Specialists * * * * * * * * * * DIABETES - NONALCOHOLIC FATTY LIVER DISEASE ...
| PowerPoint PPT presentation | free to view
Testimony of Sidney Wolfe M'D', PowerPoint PPT Presentation
Testimony of Sidney Wolfe M'D', - (mouse, rat, dog, rabbit, monkey, human).' 'Fluid accumulation leads to weight gain, ... Data from ADOPT Trial. Pre-approval and Post-Approval Clinical Evidence ...
(mouse, rat, dog, rabbit, monkey, human).' 'Fluid accumulation leads to weight gain, ... Data from ADOPT Trial. Pre-approval and Post-Approval Clinical Evidence ...
| PowerPoint PPT presentation | free to view
Drug therapy in Diabetes PowerPoint PPT Presentation
Drug therapy in Diabetes - Diarrhea and abdominal discomfort. Lactic acidosis if improperly prescribed ... Diet, exercise, Smoking, alcohol. BP. Weight. Macrovascular- CVA, IHD ...
Diarrhea and abdominal discomfort. Lactic acidosis if improperly prescribed ... Diet, exercise, Smoking, alcohol. BP. Weight. Macrovascular- CVA, IHD ...
| PowerPoint PPT presentation | free to view
DIABETES MELLITUS PowerPoint PPT Presentation
DIABETES MELLITUS - Unexplained weight loss. Fasting BS 126 or Greater. NPO at Least 8 Hours ... Unexplained weight loss. Fasting BS 126 or greater. NPO at least 8 hours ...
Unexplained weight loss. Fasting BS 126 or Greater. NPO at Least 8 Hours ... Unexplained weight loss. Fasting BS 126 or greater. NPO at least 8 hours ...
| PowerPoint PPT presentation | free to view
David Egilman, MD, MPH PowerPoint PPT Presentation
David Egilman, MD, MPH - I have served as an expert in some pharmaceutical litigation, but ... Because DTC is Pandora's Box. Pharma Knows How to Communicate with Doctors & the Public ...
I have served as an expert in some pharmaceutical litigation, but ... Because DTC is Pandora's Box. Pharma Knows How to Communicate with Doctors & the Public ...
| PowerPoint PPT presentation | free to view
Risk Management Planning Industry Experience in Implementation PowerPoint PPT Presentation
Risk Management Planning Industry Experience in Implementation - 1. Risk Management Planning. Industry Experience in ... EU QPPV Executive, Eli Lilly. 2. Risk Management A Sense of D j Vu? 'I am convinced that .
1. Risk Management Planning. Industry Experience in ... EU QPPV Executive, Eli Lilly. 2. Risk Management A Sense of D j Vu? 'I am convinced that .
| PowerPoint PPT presentation | free to download
Insulin PowerPoint PPT Presentation
Insulin - Pioglitazone has not been tested in patients with NYHA class III and IV cardiac status ... Pioglitazone (45 mg qd) LDL-C. HDL-C. TG. King AB. Diabetes Care 2000; ...
Pioglitazone has not been tested in patients with NYHA class III and IV cardiac status ... Pioglitazone (45 mg qd) LDL-C. HDL-C. TG. King AB. Diabetes Care 2000; ...
| PowerPoint PPT presentation | free to view
The Tissue Industry PowerPoint PPT Presentation
The Tissue Industry - Brian's Tragedy. 12/22/77 11/11/01. Elective Knee Surgery 11/7/01. Death three ... CDC Proves Cryolife Is Responsible For Brian's Death and Recommends Changes ...
Brian's Tragedy. 12/22/77 11/11/01. Elective Knee Surgery 11/7/01. Death three ... CDC Proves Cryolife Is Responsible For Brian's Death and Recommends Changes ...
| PowerPoint PPT presentation | free to download
Developing Risk Management Systems that meet FDA rules and dont hurt your product PowerPoint PPT Presentation
Developing Risk Management Systems that meet FDA rules and dont hurt your product - articipants should appreciate strategic and tactical elements for developing a ... used according to label instructions' [Janet Woodcock, Temple University, 4/4/00] ...
articipants should appreciate strategic and tactical elements for developing a ... used according to label instructions' [Janet Woodcock, Temple University, 4/4/00] ...
| PowerPoint PPT presentation | free to view
Oral Hypoglycemic Agents and You PowerPoint PPT Presentation
Oral Hypoglycemic Agents and You - Oral Hypoglycemic Agents and You John Kashani DO St. Josephs Medical Center New Jersey Poison Center Objectives Outline Insulin physiology, glucose regulation and ...
Oral Hypoglycemic Agents and You John Kashani DO St. Josephs Medical Center New Jersey Poison Center Objectives Outline Insulin physiology, glucose regulation and ...
| PowerPoint PPT presentation | free to view
Improving FDA PowerPoint PPT Presentation
Improving FDA - Neither I nor anyone in my division accepts personal compensation of any kind ... ostrich view: liability fears. marketing concerns. enlightened view: ...
Neither I nor anyone in my division accepts personal compensation of any kind ... ostrich view: liability fears. marketing concerns. enlightened view: ...
| PowerPoint PPT presentation | free to download
Ethical considerations in clinical trials: Drug trials PowerPoint PPT Presentation
Ethical considerations in clinical trials: Drug trials - Ethical considerations in clinical trials: Drug trials . . ...
Ethical considerations in clinical trials: Drug trials . . ...
| PowerPoint PPT presentation | free to view
Case Study PowerPoint PPT Presentation
Case Study - 2 Suppliers - Office Depot and VWR. Payments to be made via PCARD ONLY ... Identify additional users of Office Depot and VWR. Refine Supplier Adoption Process ...
2 Suppliers - Office Depot and VWR. Payments to be made via PCARD ONLY ... Identify additional users of Office Depot and VWR. Refine Supplier Adoption Process ...
| PowerPoint PPT presentation | free to view
Potential role of PPAR activation in CV risk reduction PowerPoint PPT Presentation
Potential role of PPAR activation in CV risk reduction - VBWG. Potential role of PPAR activation. in CV ... 2003;302:406-7. Peroxisome proliferator-activator. receptors ... Pioglitazone Actos Eli Lilly/ 1999 Takeda ...
VBWG. Potential role of PPAR activation. in CV ... 2003;302:406-7. Peroxisome proliferator-activator. receptors ... Pioglitazone Actos Eli Lilly/ 1999 Takeda ...
| PowerPoint PPT presentation | free to view
Diabetes type 2 PowerPoint PPT Presentation
Diabetes type 2 - Title: PowerPoint Presentation Last modified by: Michiel Van Damme Created Date: 1/1/1601 12:00:00 AM Document presentation format: Diavoorstelling
Title: PowerPoint Presentation Last modified by: Michiel Van Damme Created Date: 1/1/1601 12:00:00 AM Document presentation format: Diavoorstelling
| PowerPoint PPT presentation | free to view
Treatment of Type II Diabetes Mellitus PowerPoint PPT Presentation
Treatment of Type II Diabetes Mellitus - Treatment of Type II Diabetes Mellitus Bradley Alger M.D. Denver Family Medicine. St. Joseph Hospital Family Medicine Residency. Goals of Treatment Reduce the risk of ...
Treatment of Type II Diabetes Mellitus Bradley Alger M.D. Denver Family Medicine. St. Joseph Hospital Family Medicine Residency. Goals of Treatment Reduce the risk of ...
| PowerPoint PPT presentation | free to download
Cheminformatics PowerPoint PPT Presentation
Cheminformatics - The less favourable conformation (b) has atoms in eclipsed configuration. ... of a tetrahedrally coordinated saturated carbon atom in an organic molecule ...
The less favourable conformation (b) has atoms in eclipsed configuration. ... of a tetrahedrally coordinated saturated carbon atom in an organic molecule ...
| PowerPoint PPT presentation | free to download
Developing Risk Management Systems that meet FDA rules ---and don PowerPoint PPT Presentation
Developing Risk Management Systems that meet FDA rules ---and don - Title: Developing Consumer Marketing Claims within the Clinical Development Process Author: Lou Morris Last modified by: Lou Created Date: 9/29/2000 3:30:09 PM
Title: Developing Consumer Marketing Claims within the Clinical Development Process Author: Lou Morris Last modified by: Lou Created Date: 9/29/2000 3:30:09 PM
| PowerPoint PPT presentation | free to download
Update in Diabetes Management Oral Therapies PowerPoint PPT Presentation
Update in Diabetes Management Oral Therapies - Update in Diabetes Management Oral Therapies. Amy M. Lugo, PharmD, BCPS, CDM ... Use in premenopausal anovulatory women may cause resumption of ovulation ...
Update in Diabetes Management Oral Therapies. Amy M. Lugo, PharmD, BCPS, CDM ... Use in premenopausal anovulatory women may cause resumption of ovulation ...
| PowerPoint PPT presentation | free to view
ACTUALIZACIN DE ANTIDIABTICOS ORALES PowerPoint PPT Presentation
ACTUALIZACIN DE ANTIDIABTICOS ORALES - S ndrome caracterizado por la presencia de hiperglucemia, asociada a ... Seg n American Association of Clinical Endocrinologists. OBJETIVOS DE CONTROL ...
S ndrome caracterizado por la presencia de hiperglucemia, asociada a ... Seg n American Association of Clinical Endocrinologists. OBJETIVOS DE CONTROL ...
| PowerPoint PPT presentation | free to view
Developing a RiskMAP PowerPoint PPT Presentation
Developing a RiskMAP - promotional techniques to publicize risk management (e.g., ... alternative therapy available and reversibility of adverse events preventability of the adverse event, ...
promotional techniques to publicize risk management (e.g., ... alternative therapy available and reversibility of adverse events preventability of the adverse event, ...
| PowerPoint PPT presentation | free to download
FDA Regulation of New Drugs and Medical Devices PowerPoint PPT Presentation
FDA Regulation of New Drugs and Medical Devices - How long do you think it will be before we can test this in patients? Using ... Died February, 2003 of heatstroke following taking an over-the-counter product ...
How long do you think it will be before we can test this in patients? Using ... Died February, 2003 of heatstroke following taking an over-the-counter product ...
| PowerPoint PPT presentation | free to view
Animal Experiments: Can We Do Better PowerPoint PPT Presentation
Animal Experiments: Can We Do Better - The human cortex has 10X the surface area of that of the rhesus monkey ... Specific brain regions not present in monkeys. Why Animal Experiments Fail: ...
The human cortex has 10X the surface area of that of the rhesus monkey ... Specific brain regions not present in monkeys. Why Animal Experiments Fail: ...
| PowerPoint PPT presentation | free to view
PRACTICAL INSULIN USE or, how to think like a pancreas PowerPoint PPT Presentation
PRACTICAL INSULIN USE or, how to think like a pancreas - PRACTICAL INSULIN USE or, how to think like a pancreas Oliver Z. Graham, MD Department of Internal Medicine Virtual Endocrinologist Types of Insulin Types of Insulin ...
PRACTICAL INSULIN USE or, how to think like a pancreas Oliver Z. Graham, MD Department of Internal Medicine Virtual Endocrinologist Types of Insulin Types of Insulin ...
| PowerPoint PPT presentation | free to view
Updates on the use of biologic therapies in AS PowerPoint PPT Presentation
Updates on the use of biologic therapies in AS - Exclusion: ankylosis prior anti-TNF. Other: stable NSAIDS/DMARDS and prednisone ... Effect of biologics on established ankylosis/ and on disease progression ? ...
Exclusion: ankylosis prior anti-TNF. Other: stable NSAIDS/DMARDS and prednisone ... Effect of biologics on established ankylosis/ and on disease progression ? ...
| PowerPoint PPT presentation | free to view
A MultiHeaded Hydra Turned Medicine into Snake Oil Vera Sharav Alliance for Human Research Protectio PowerPoint PPT Presentation
A MultiHeaded Hydra Turned Medicine into Snake Oil Vera Sharav Alliance for Human Research Protectio - Dr. Bruce Pollack (U. Pitts) signed it. The Journal of Clinical ... David Willis, M.D., Medical Director, NW Institute. Pediatric News, January, 2004 ...
Dr. Bruce Pollack (U. Pitts) signed it. The Journal of Clinical ... David Willis, M.D., Medical Director, NW Institute. Pediatric News, January, 2004 ...
| PowerPoint PPT presentation | free to view
G. Steven Burrill, CEO PowerPoint PPT Presentation
G. Steven Burrill, CEO - Exclusive focus on Life Sciences. Human Healthcare (Rx and Dx) Nutraceuticals/Wellness ... ALZA (`68) Cetus (`71) Amgen (`80), Genentech (`76 ) Biogen (`78) ...
Exclusive focus on Life Sciences. Human Healthcare (Rx and Dx) Nutraceuticals/Wellness ... ALZA (`68) Cetus (`71) Amgen (`80), Genentech (`76 ) Biogen (`78) ...
| PowerPoint PPT presentation | free to view
Diabetes type 2 PowerPoint PPT Presentation
Diabetes type 2 - ... verlagen LDL, TG en FFA ... behandeling Op die manier verbetering van cardiovasculaire prognose en microvasculaire complicaties Double jeopardy ...
... verlagen LDL, TG en FFA ... behandeling Op die manier verbetering van cardiovasculaire prognose en microvasculaire complicaties Double jeopardy ...
| PowerPoint PPT presentation | free to view
Monitoring the Safety of FDAApproved Drugs: A Legislative Review PowerPoint PPT Presentation
Monitoring the Safety of FDAApproved Drugs: A Legislative Review - For the FDA, this will require a continuous availability of new data and ongoing, ... FDA estimates 8 year time-span for entire process ...
For the FDA, this will require a continuous availability of new data and ongoing, ... FDA estimates 8 year time-span for entire process ...
| PowerPoint PPT presentation | free to view
Diabetes Mellitus Type 2 PowerPoint PPT Presentation
Diabetes Mellitus Type 2 - decrease sensation (mono-filament test) decrease Achilles reflex. decrease vibratory sensation. Treatments. Prevention (primary and secondary) ...
decrease sensation (mono-filament test) decrease Achilles reflex. decrease vibratory sensation. Treatments. Prevention (primary and secondary) ...
| PowerPoint PPT presentation | free to view
Some Things You May Be Interested In With Regard To Therapy for Type 2 Diabetes PowerPoint PPT Presentation
Some Things You May Be Interested In With Regard To Therapy for Type 2 Diabetes - Some Things You May Be Interested In With Regard To Therapy for Type 2 Diabetes
Some Things You May Be Interested In With Regard To Therapy for Type 2 Diabetes
| PowerPoint PPT presentation | free to view
PENGGUNAAN OBAT RASIONAL PowerPoint PPT Presentation
PENGGUNAAN OBAT RASIONAL - 'The standing practice, or methods of a professional, as distinguished from those ... (Obat yg tak berguna) obat tetes mata katarak .dsb. Evidence-Based Medicine ...
'The standing practice, or methods of a professional, as distinguished from those ... (Obat yg tak berguna) obat tetes mata katarak .dsb. Evidence-Based Medicine ...
| PowerPoint PPT presentation | free to view
Insulin Resistance and Cardiovascular Disease: PowerPoint PPT Presentation
Insulin Resistance and Cardiovascular Disease: - III. Insulin sensitizers: Surrogate and clinical. outcomes studies. IV. ... N = 266 Hispanic women with gestational diabetes randomized ...
III. Insulin sensitizers: Surrogate and clinical. outcomes studies. IV. ... N = 266 Hispanic women with gestational diabetes randomized ...
| PowerPoint PPT presentation | free to view
Update on diabetes type 2 PowerPoint PPT Presentation
Update on diabetes type 2 - time. intervention. N. Pop. Study. Insulin. Resistance. Type 2. Diabetes. b-cell. Dysfunction ... of high vascular risk patients based on waist and age ...
time. intervention. N. Pop. Study. Insulin. Resistance. Type 2. Diabetes. b-cell. Dysfunction ... of high vascular risk patients based on waist and age ...
| PowerPoint PPT presentation | free to view
AVANDIA Liability, Science, PowerPoint PPT Presentation
AVANDIA Liability, Science, - Avandia lowers blood glucose primarily by increasing insulin ... of data has obfuscated relatively straightforward conclusions evident from the FDA data sets. ...
Avandia lowers blood glucose primarily by increasing insulin ... of data has obfuscated relatively straightforward conclusions evident from the FDA data sets. ...
| PowerPoint PPT presentation | free to view
Manejo de diabetes: el reto de una condicin crnica PowerPoint PPT Presentation
Manejo de diabetes: el reto de una condicin crnica - Diabetes Mellitus (DM) es un desorden metab lico cr nico causado por una ... Insulin sensitivity factor (ISF) determines how much 1U of insulin is expected ...
Diabetes Mellitus (DM) es un desorden metab lico cr nico causado por una ... Insulin sensitivity factor (ISF) determines how much 1U of insulin is expected ...
| PowerPoint PPT presentation | free to view
Responsibilities of Investigators PowerPoint PPT Presentation
Responsibilities of Investigators - 'Research integrity may be defined as active adherence to the ... Paxil failed to acknowledge threat of suicide in adolescents. Fiduciary Responsibilities ...
'Research integrity may be defined as active adherence to the ... Paxil failed to acknowledge threat of suicide in adolescents. Fiduciary Responsibilities ...
| PowerPoint PPT presentation | free to view
PowerPoint PPT Presentation
- The FDA: Watchdog Without a Bite (and With No Incentive to Bark) Joe Lex, MD, FAAEM Temple University School of Medicine Philadelphia, PA Joseph.Lex@TUHS.Temple.edu
The FDA: Watchdog Without a Bite (and With No Incentive to Bark) Joe Lex, MD, FAAEM Temple University School of Medicine Philadelphia, PA Joseph.Lex@TUHS.Temple.edu
| PowerPoint PPT presentation | free to download
The Pharmaceutical Industry Martin Donohoe, MD, FACP
The Pharmaceutical Industry Martin Donohoe, MD, FACP - Pharmaceutical Industry Martin Donohoe, MD, FACP The Pharmaceutical Industry Outline Economics drug costs drug development Research Marketing Drug Regulation/The FDA ...
Pharmaceutical Industry Martin Donohoe, MD, FACP The Pharmaceutical Industry Outline Economics drug costs drug development Research Marketing Drug Regulation/The FDA ...
The Pharmaceutical Industry Martin Donohoe, MD, FACP
The Pharmaceutical Industry Martin Donohoe, MD, FACP - Bush/Congressional prescription drug benefit proposals woefully inadequate ... 2001 California Medicare Prescription Drug Discount Program ...
Bush/Congressional prescription drug benefit proposals woefully inadequate ... 2001 California Medicare Prescription Drug Discount Program ...


Home About Us Terms and Conditions Privacy Policy Contact Us
Copyright 2024 CrystalGraphics, Inc. — All rights Reserved. PowerShow.com is a trademark of CrystalGraphics, Inc.
rezulin — Search results on PowerShow.com